Literature DB >> 11038212

Persistent hyperparathyroidism requiring surgical treatment after kidney transplantation.

P Kinnaert1, N Nagy, C Decoster-Gervy, L De Pauw, I Salmon, P Vereerstraeten.   

Abstract

There are not many publications describing long-term follow-up of persistent hyperparathyroidism requiring surgical treatment after kidney transplantation (PHSKT). In some patients adenomas, rather than multiglandular disease, have been incriminated as the cause of PHSKT. We reviewed the charts of 45 patients followed for 12 to 146 months (median 45 months) after parathyroidectomy for PHSKT. We compared them with (1) those of 951 patients receiving a kidney graft during the same period but not submitted to parathyroidectomy or (2) 90 matched controls selected from this cohort to determine the characteristics of PHSKT patients. The duration of pretransplant dialysis was significantly longer in PHSKT patients than in controls (5.78 +/- 0.41 vs. 3.41 +/- 0.24 years; p < 0.0001). A total of 166 glands were removed or biopsied. Except for one questionable case, no true adenoma was observed even when only one gland was enlarged. The outcome of surgery was not influenced by the technique (subtotal parathyroidectomy versus total parathyroidectomy and autografting) but depended on the amount of resected parathyroid tissue: no failures and 4 cases of hypoparathyroidism in 34 cases with no missing gland at cervical exploration; 3 failures and no permanent hypoparathyroidism in 11 cases with one or two missing glands. Excision of the enlarged glands only was sufficient to cure the patient. No recurrence was observed. Our results suggest that single gland enlargement in PHSKT results in most cases from different rates of involution of the parathyroids after successful kidney transplantation. When fewer than four glands are discovered, resection of all visible glands with or without grafting corrects hypercalcemia in more than 70% of the cases.

Entities:  

Mesh:

Year:  2000        PMID: 11038212     DOI: 10.1007/s002680010230

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  6 in total

1.  Initial parathyroid surgery in 606 patients with renal hyperparathyroidism.

Authors:  Ralph Schneider; Emily P Slater; Elias Karakas; Detlef K Bartsch; Katja Schlosser
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

Review 2.  The surgical management of renal hyperparathyroidism.

Authors:  Catherine Madorin; Randall P Owen; William D Fraser; Phillip K Pellitteri; Brian Radbill; Alessandra Rinaldo; Raja R Seethala; Ashok R Shaha; Carl E Silver; Matthew Y Suh; Barrie Weinstein; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-20       Impact factor: 2.503

3.  Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation.

Authors:  Emad Kandil; Sandy Florman; Haythem Alabbas; Obai Abdullah; Jennifer McGee; Salem Noureldine; Douglas Slakey; Rubin Zhang
Journal:  Am J Med Sci       Date:  2010-05       Impact factor: 2.378

4.  Total parathyroidectomy without autotransplantation after renal transplantation for tertiary hyperparathyroidism: long-term follow-up.

Authors:  Hazim M Sadideen; John D Taylor; David J Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-10-14       Impact factor: 2.370

5.  Graft-dependent renal hyperparathyroidism despite successful kidney transplantation.

Authors:  K Schlosser; M Rothmund; K Maschuw; P J Barth; T P Vahl; K L Suchan; E Domínguez Fernández
Journal:  World J Surg       Date:  2008-04       Impact factor: 3.352

6.  Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidism: TOPAR PILOT-Trial.

Authors:  Katja Schlosser; Johannes A Veit; Stefan Witte; Emilio Domínguez Fernández; Norbert Victor; Hans-Peter Knaebel; Christoph M Seiler; Matthias Rothmund
Journal:  Trials       Date:  2007-09-18       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.